Management of Chemotherapy associated Anemia through Nagaphani fruit

Phase 3

Completed

• Conditions: Other specified anemias,

• Registration Number: CTRI/2020/07/026593
• Lead Sponsor: Institute for Post Graduate Teaching and Research in Ayurveda

Brief Summary

An open labeled randomized controlled clinical trial will be carried out to assess the efficacy of Nagaphani (Opuntia elatior Mill.) fruit juice in chemotherapy associated Anemia on a minimum of 30 patients in the dose of 40 ml per day orally before meal in two divided doses for a duration of 60 days and followup of 30 days  will be carried out along with conventional treatment protocol and compared with conventional group

Detailed Description

Not available

Study Timeline

• Study Start: 2020-08-16
• Study Completion: 2022-01-22
• Last Update Posted: 2024-02-28

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Any type of Cancer patients under Chemotherapy associated with Anemia Hb% below 12gm for female and below 13gm for male or reduced RBC count.

Exclusion Criteria

Patient who are not under Chemotherapy Pregnancy and Lactation Severe Renal/Hepatic/Cardiac disease Any continuing blood loss Hemoglobin percentage below 6gm.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Increase in Hb percentage	60 days

Secondary Outcome Measures

Name	Time	Method
Increased RBC count	60 days

Trial Locations

Locations (1)

PG Ayurveda Hospital; 🇮🇳 Jamnagar, GUJARAT, India

PG Ayurveda Hospital

🇮🇳Jamnagar, GUJARAT, India

Sharada Ramesh

Principal investigator

9620554829

dr.shaaradaramesh@gmail.com